Biblio

Export 144 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
T. Minh Do, Dodacki, A., Alata, W., Calon, F., Nicolic, S., Scherrmann, J. - M., Farinotti, R., and Bourasset, F., “Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).”, J Alzheimers Dis, vol. 49, no. 2, pp. 287-300, 2016.
V. I. Dobromyslin and Megherbi, D. B., “Augmenting Imaging Biomarker Performance with Blood-Based Gene Expression Levels for Predicting Alzheimer's Disease Progression.”, J Alzheimers Dis, vol. 87, no. 2, pp. 583-594, 2022.
A. Dodich, Cerami, C., Crespi, C., Canessa, N., Lettieri, G., Iannaccone, S., Marcone, A., Cappa, S. F., and Cacioppo, J. T., “Differential Impairment of Cognitive and Affective Mentalizing Abilities in Neurodegenerative Dementias: Evidence from Behavioral Variant of Frontotemporal Dementia, Alzheimer's Disease, and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1011-22, 2016.
A. Dodich, Cerami, C., Cappa, S. F., Marcone, A., Golzi, V., Zamboni, M., Giusti, M. Cristina, and Iannaccone, S., “Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.”, J Alzheimers Dis, vol. 61, no. 2, pp. 761-772, 2018.
J. D. Doecke, Rembach, A., Villemagne, V. L., Varghese, S., Rainey-Smith, S., Sarros, S., Evered, L. A., Fowler, C. J., Pertile, K. K., Rumble, R. L., Trounson, B., Taddei, K., Laws, S. M., S Macaulay, L., Bush, A. I., Ellis, K. A., Martins, R., Ames, D., Silbert, B., Vanderstichele, H., Masters, C. L., Darby, D. G., Li, Q. - X., and Collins, S., “Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.”, J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
T. Doi, Shimada, H., Makizako, H., Tsutsumimoto, K., Verghese, J., and Suzuki, T., “Motoric Cognitive Risk Syndrome: Association with Incident Dementia and Disability.”, J Alzheimers Dis, vol. 59, no. 1, pp. 77-84, 2017.
A. J. Doig, “Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis.”, J Alzheimers Dis, vol. 66, no. 1, pp. 25-36, 2018.
J. Dominguez, de Guzman, M. Fe, Reandelar, M., and Phung, T. Kieu Thi, “Prevalence of Dementia and Associated Risk Factors: A Population-Based Study in the Philippines.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1065-1073, 2018.
M. Domínguez-Prieto, Velasco, A., Tabernero, A., and Medina, J. M., “Endocytosis and Transcytosis of Amyloid-β Peptides by Astrocytes: A Possible Mechanism for Amyloid-β Clearance in Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1109-1124, 2018.
M. Domínguez-Prieto, Velasco, A., Vega, L., Tabernero, A., and Medina, J. M., “Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-β Peptides: Protective Effect of Human Serum Albumin.”, J Alzheimers Dis, vol. 55, no. 1, pp. 171-182, 2017.
C. Domínguez-Vivero, Wu, L., Lee, S., Manoochehri, M., Cines, S., Brickman, A. M., Rizvi, B., Chesebro, A., Gazes, Y., Fallon, E., Lynch, T., Heidebrink, J. L., Paulson, H., Goldman, J. S., Huey, E., and Cosentino, S., “Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”, J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.
Y. Dong and Brewer, G. J., “Global Metabolic Shifts in Age and Alzheimer's Disease Mouse Brains Pivot at NAD +/NADH Redox Sites.”, J Alzheimers Dis, vol. 71, no. 1, pp. 119-140, 2019.
J. Dong, Qin, W., Wei, C., Tang, Y., Wang, Q., and Jia, J., “A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-β Production and Tau Phosphorylation.”, J Alzheimers Dis, vol. 57, no. 2, pp. 613-623, 2017.
Y. - T. Dong, Cao, K., Tan, L. - C., Wang, X. - L., Qi, X. - L., Xiao, Y., and Guan, Z. - Z., “Stimulation of SIRT1 Attenuates the Level of Oxidative Stress in the Brains of APP/PS1 Double Transgenic Mice and in Primary Neurons Exposed to Oligomers of the Amyloid-β Peptide.”, J Alzheimers Dis, vol. 63, no. 1, pp. 283-301, 2018.
N. J. Donovan, Hsu, D. C., Dagley, A. S., Schultz, A. P., Amariglio, R. E., Mormino, E. C., Okereke, O. I., Rentz, D. M., Johnson, K. A., Sperling, R. A., and Marshall, G. A., “Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults.”, J Alzheimers Dis, 2015.
R. S. Doody, Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., Siemers, E., Liu-Seifert, H., and Mohs, R., “Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 311-21, 2014.
E. Doran, Keator, D., Head, E., Phelan, M. J., Kim, R., Totoiu, M., Barrio, J. R., Small, G. W., Potkin, S. G., and Lott, I. T., “Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.”, J Alzheimers Dis, vol. 56, no. 2, pp. 459-470, 2017.
E. Dorey, Bamji-Mirza, M., Najem, D., Li, Y., Liu, H., Callaghan, D., Walker, D., Lue, L. - F., Stanimirovic, D., and Zhang, W., “Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1265-1279, 2017.
F. Dorninger, Moser, A. B., Kou, J., Wiesinger, C., Forss-Petter, S., Gleiss, A., Hinterberger, M., Jungwirth, S., Fischer, P., and Berger, J., “Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging.”, J Alzheimers Dis, vol. 62, no. 2, pp. 841-854, 2018.
Y. Dou, Liu, S., Li, Y., Wu, H., Chen, H., and Ji, Y., “Plasma Cholesterol Levels as Potential Nutritional Biomarkers for Lewy Body Dementia.”, J Alzheimers Dis, vol. 86, no. 2, pp. 779-786, 2022.
R. J. Dougherty, Lindheimer, J. B., Stegner, A. J., Van Riper, S., Okonkwo, O. C., and Cook, D. B., “An Objective Method to Accurately Measure Cardiorespiratory Fitness in Older Adults Who Cannot Satisfy Widely Used Oxygen Consumption Criteria.”, J Alzheimers Dis, vol. 61, no. 2, pp. 601-611, 2018.
R. J. Dougherty, Schultz, S. A., Kirby, T. K., Boots, E. A., Oh, J. M., Edwards, D., Gallagher, C. L., Carlsson, C. M., Bendlin, B. B., Asthana, S., Sager, M. A., Hermann, B. P., Christian, B. T., Johnson, S. C., Cook, D. B., and Okonkwo, O. C., “Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1089-1097, 2017.
A. Douglass, Walterfang, M., Velakoulis, D., and Abel, L., “Behavioral Variant Frontotemporal Dementia Performance on a Range of Saccadic Tasks.”, J Alzheimers Dis, vol. 65, no. 1, pp. 231-242, 2018.
A. Douros, Santella, C., Dell'Aniello, S., Azoulay, L., Renoux, C., Suissa, S., and Brassard, P., “Infectious Disease Burden and the Risk of Alzheimer's Disease: A Population-Based Study.”, J Alzheimers Dis, vol. 81, no. 1, pp. 329-338, 2021.
B. Downer, Veeranki, S. P., and Wong, R., “A Late Life Risk Index for Severe Cognitive Impairment in Mexico.”, J Alzheimers Dis, vol. 52, no. 1, pp. 191-203, 2016.

Pages